Iksuda Therapeutics (Iksuda), the developer of a new generation of antibody drug conjugates (ADCs) with raised therapeutic index, has announced
Read more
Home ยป
Therapeutics
park ambiente friedberg
A new Phase 3 trial to test the safety and efficacy of therapeutics for COVID-19 has begun enrolling patients hospitalized
Read more
Linear epitope mapping of the SARS-CoV-2 spike protein
The spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been the primary target of many drug discovery
Read more
Do Artemisia annua L. compounds have SARS-CoV-2 antiviral potential?
Caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the ongoing coronavirus disease 2019 (COVID-19) pandemic has led to over
Read more
protonix sleep
The mosquito protein AEG12 strongly inhibits the family of viruses that cause yellow fever, dengue, West Nile, and Zika and
Read more
amoxicillin suspension dose
When people hear botulinum toxin, they often think one of two things: a cosmetic that makes frown lines disappear or
Read more
Scientists discover new immunotherapy target for malignant brain tumors
Scientists say they have discovered a potential new target for immunotherapy of malignant brain tumors, which so far have resisted
Read more
Could graphene be an effective antiviral platform against SARS-CoV-2?
The coronavirus disease 2019 (COVID-19) pandemic continues to take a heavy toll on human life and economic well-being. Caused by
Read more